1
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Campbell HD, Schimansky T, Claudianos C,
Ozsarac N, Kasprzak AB, Cotsell JN, Young IG, de Couet HG and
Miklos GL: The Drosophila melanogaster flightless-I gene involved
in gastrulation and muscle degeneration encodes gelsolin-like and
leucine-rich repeat domains and is conserved in Caenorhabditis
elegans and humans. Proc Natl Acad Sci USA. 90:11386–11390. 1993.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Campbell HD, Fountain S, Young IG,
Claudianos C, Hoheisel JD, Chen K-S and Lupski JR: Genomic
structure, evolution, and expression of human FLII, a gelsolin and
leucine-rich-repeat family member: Overlap with LLGL. Genomics.
42:46–54. 1997. View Article : Google Scholar : PubMed/NCBI
|
4
|
Davy DA, Ball EE, Matthaei KI, Campbell HD
and Crouch MF: The flightless I protein localizes to actin-based
structures during embryonic development. Immunol Cell Biol.
78:423–429. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Campbell HD, Fountain S, McLennan IS,
Berven LA, Crouch MF, Davy DA, Hooper JA, Waterford K, Chen K-S,
Lupski JR, et al: Fliih, a gelsolin-related cytoskeletal regulator
essential for early mammalian embryonic development. Mol Cell Biol.
22:3518–3526. 2002. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang T, Chuang T-H, Ronni T, Gu S, Du Y-C,
Cai H, Sun H-Q, Yin HL and Chen X: Flightless I homolog negatively
modulates the TLR pathway. J Immunol. 176:1355–1362. 2006.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Cowin AJ, Adams DH, Strudwick XL, Chan H,
Hooper JA, Sander GR, Rayner TE, Matthaei KI, Powell BC and
Campbell HD: Flightless I deficiency enhances wound repair by
increasing cell migration and proliferation. J Pathol. 211:572–581.
2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li J, Yin HL and Yuan J: Flightless-I
regulates proinflammatory caspases by selectively modulating
intracellular localization and caspase activity. J Cell Biol.
181:321–333. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kopecki Z, Yang GN, Arkell RM, Jackson JE,
Melville E, Iwata H, Ludwig RJ, Zillikens D, Murrell DF and Cowin
AJ: Flightless I over-expression impairs skin barrier development,
function and recovery following skin blistering. J Pathol.
232:541–552. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wu L, Chen H, Zhu Y, Meng J, Li Y, Li M,
Yang D, Zhang P, Feng M and Tong X: Flightless I homolog negatively
regulates ChREBP activity in cancer cells. Int J Biochem Cell Biol.
45:2688–2697. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Jeong KW: Flightless I (Drosophila)
homolog facilitates chromatin accessibility of the estrogen
receptor α target genes in MCF-7 breast cancer cells. Biochem
Biophys Res Commun. 446:608–613. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kopecki Z, Yang GN, Jackson JE, Melville
EL, Calley MP, Murrell DF, Darby IA, O'Toole EA, Samuel MS and
Cowin AJ: Cytoskeletal protein Flightless I inhibits apoptosis,
enhances tumor cell invasion and promotes cutaneous squamous cell
carcinoma progression. Oncotarget. 6:36426–36440. 2015.PubMed/NCBI
|
13
|
Wang T, Song W, Chen Y, Chen R, Liu Z, Wu
L, Li M, Yang J, Wang L, Liu J, et al: Flightless I homolog
represses prostate cancer progression through targeting androgen
receptor signaling. Clin Cancer Res. 22:1531–1544. 2016. View Article : Google Scholar
|
14
|
Stone L: Bladder cancer: In the driving
seat - AGL loss drives tumour growth. Nat Rev Urol. 13:3. 2016.
View Article : Google Scholar
|
15
|
Liu Y-T and Yin HL: Identification of the
binding partners for flightless I, A novel protein bridging the
leucine-rich repeat and the gelsolin superfamilies. J Biol Chem.
273:7920–7927. 1998. View Article : Google Scholar : PubMed/NCBI
|
16
|
Fong KS and de Couet HG: Novel proteins
interacting with the leucine-rich repeat domain of human
flightless-I identified by the yeast two-hybrid system. Genomics.
58:146–157. 1999. View Article : Google Scholar : PubMed/NCBI
|
17
|
Luo W, Slebos RJ, Hill S, Li M, Brábek J,
Amanchy R, Chaerkady R, Pandey A, Ham A-JL and Hanks SK: Global
impact of oncogenic Src on a phosphotyrosine proteome. J Proteome
Res. 7:3447–3460. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Esposito AM, Mateyak M, He D, Lewis M,
Sasikumar AN, Hutton J, Copeland PR and Kinzy TG: Eukaryotic
polyribosome profile analysis. J Vis Exp. pii; pp. 19482010,
View Article : Google Scholar
|
19
|
Rajkumar AP, Qvist P, Lazarus R, Lescai F,
Ju J, Nyegaard M, Mors O, Børglum AD, Li Q and Christensen JH:
Experimental validation of methods for differential gene expression
analysis and sample pooling in RNA-seq. BMC Genomics. 16:5482015.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Huang Q, Gumireddy K, Schrier M, le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ström A-C and Weis K: Importin-beta-like
nuclear transport receptors. Genome Biol. 2:S30082001. View Article : Google Scholar
|
22
|
Yi R, Qin Y, Macara IG and Cullen BR:
Exportin-5 mediates the nuclear export of pre-microRNAs and short
hairpin RNAs. Genes Dev. 17:3011–3016. 2003. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hutten S and Kehlenbach RH: Nup214 is
required for CRM1-dependent nuclear protein export in vivo. Mol
Cell Biol. 26:6772–6785. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Vincendeau M, Nagel D, Brenke JK,
Brack-Werner R and Hadian K: Heterogenous nuclear ribonucleoprotein
Q increases protein expression from HIV-1 Rev-dependent
transcripts. Virol J. 10:1512013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Svitkin YV, Yanagiya A, Karetnikov AE,
Alain T, Fabian MR, Khoutorsky A, Perreault S, Topisirovic I and
Sonenberg N: Control of translation and miRNA-dependent repression
by a novel poly(A) binding protein, hnRNP-Q. PLoS Biol.
11:e10015642013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Shimizu Y, Nishitsuji H, Marusawa H, Ujino
S, Takaku H and Shimotohno K: The RNA-editing enzyme APOBEC1
requires heterogeneous nuclear ribonucleoprotein Q isoform 6 for
efficient interaction with interleukin-8 mRNA. J Biol Chem.
289:26226–26238. 2014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Beuck C, Williamson JR, Wüthrich K and
Serrano P: The acidic domain is a unique structural feature of the
splicing factor SyNCRIP. Protein Sci. 25:1545–1550. 2016.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Kaul G, Pattan G and Rafeequi T:
Eukaryotic elongation factor-2 (eEF2): Its regulation and peptide
chain elongation. Cell Biochem Funct. 29:227–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Kopecki Z and Cowin AJ: Flightless I: An
actin-remodelling protein and an important negative regulator of
wound repair. Int J Biochem Cell Biol. 40:1415–1419. 2008.
View Article : Google Scholar
|
30
|
Lee Y-H, Campbell HD and Stallcup MR:
Developmentally essential protein flightless I is a nuclear
receptor coactivator with actin binding activity. Mol Cell Biol.
24:2103–2117. 2004. View Article : Google Scholar : PubMed/NCBI
|
31
|
Archer S, Behm C, Hooper J, Judge R,
Matthaei K, Powell B, Cowin A and Campbell H: A novel,
evolutionarily conserved role in intracellular signalling for the
gelsolin-related actin-binding protein Flightless I. The FEBS
Journal. 272:2822005.
|
32
|
Orloff G, Allen P, Miklos G, Young I,
Campbell H and Kwiatkowski D: Human flightless-I has actin-binding
ability. Molecular Biology of the Cell. 6:8031995.
|
33
|
Jeong KW, Lee Y-H and Stallcup MR:
Recruitment of the SWI/SNF chromatin remodeling complex to steroid
hormone-regulated promoters by nuclear receptor coactivator
flightless-I. J Biol Chem. 284:29298–29309. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Marei H, Carpy A, Woroniuk A, Vennin C,
White G, Timpson P, Macek B and Malliri A: Differential Rac1
signalling by guanine nucleotide exchange factors implicates FLII
in regulating Rac1-driven cell migration. Nat Commun. 7:106642016.
View Article : Google Scholar : PubMed/NCBI
|
35
|
van Deursen J, Boer J, Kasper L and
Grosveld G: G2 arrest and impaired nucleocytoplasmic transport in
mouse embryos lacking the proto-oncogene CAN/Nup214. EMBO J.
15:5574–5583. 1996.PubMed/NCBI
|
36
|
Bernad R, Engelsma D, Sanderson H,
Pickersgill H and Fornerod M: Nup214-Nup88 nucleoporin subcomplex
is required for CRM1-mediated 60 S preribosomal nuclear export. J
Biol Chem. 281:19378–19386. 2006. View Article : Google Scholar : PubMed/NCBI
|
37
|
Carmody SR and Wente SR: mRNA nuclear
export at a glance. J Cell Sci. 122:1933–1937. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Simon DN and Rout MP: Cancer and the
nuclear pore complex. Cancer Biology and the Nuclear Envelope.
Schirmer EC and de las Heras JI: Springer; New York: pp. 285–307.
2014, View Article : Google Scholar
|
39
|
Mazan-Mamczarz K, Lal A, Martindale JL,
Kawai T and Gorospe M: Translational repression by RNA-binding
protein TIAR. Mol Cell Biol. 26:2716–2727. 2006. View Article : Google Scholar : PubMed/NCBI
|